Evaluation of calculating carboplatin dosage in carboplatin–pemetrexed therapy as the first‐line therapy for Chinese patients with advanced lung adenocarcinoma

OBJECTIVE: This study aims to explore the application of actual carboplatin in carboplatin plus pemetrexed regimen as first‐line treatment for advanced lung adenocarcinoma, and to determine the recommended dose of carboplatin for Chinese populations. METHODS: From January 2014 to April 2016, 151 adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yixiang, Xing, Puyuan, Wang, Shouzheng, Ma, Di, Mu, Yuxin, Li, Xue, Xu, Ziyi, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832477/
https://www.ncbi.nlm.nih.gov/pubmed/29377581
http://dx.doi.org/10.1111/1759-7714.12594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832477/
https://www.ncbi.nlm.nih.gov/pubmed/29377581
http://dx.doi.org/10.1111/1759-7714.12594

Ejemplares similares